Migraine is a complex neurological disorder that affects millions of people globally. Characterized by recurring, often debilitating headaches, migraines can significantly impact an individual’s quality of life, productivity, and overall well-being. As the prevalence of migraines continues to rise, the migraine market has become a major focus for pharmaceutical companies and healthcare providers. This article will explore the current trends in the migraine market, available treatments, key players, and what the future holds for this rapidly evolving field.